Toledo, Rodrigo A <br/><br/>
Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  08 2018 
 - 3550-3559 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-0103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplastic Lymphoma Kinase--genetics<br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Biomarkers, Tumor--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--genetics<br/>Cell-Free Nucleic Acids--blood<br/>Class I Phosphatidylinositol 3-Kinases--genetics<br/>Colorectal Neoplasms--blood<br/>ErbB Receptors--genetics<br/>Exome--genetics<br/>Female<br/>Heterografts<br/>Humans<br/>Mice<br/>Mutation<br/>Neovascularization, Pathologic--blood<br/>Protein Conformation--drug effects<br/>Proto-Oncogene Proteins c-abl--genetics<br/>Vascular Endothelial Growth Factor A--genetics<br/>Vascular Endothelial Growth Factor Receptor-2--blood<br/>Exome Sequencing